Delayed re-exploration for bleeding after coronary artery bypass surgery results in adverse outcomes

被引:56
作者
Choong, Cliff K.
Gerrard, Caroline
Goldsmith, Kimberley A.
Dunningham, Helen
Vuylsteke, Alain
机构
[1] Papworth Hosp, NHS Trust, Cambridge CB3 8RE, England
[2] Univ Cambridge, Cambridge, England
[3] Papworth Hosp NHS Trust, Cambridge Perfus Serv, Cambridge, England
基金
英国医学研究理事会;
关键词
re-exploration; coronary; surgery; bleeding;
D O I
10.1016/j.ejcts.2007.02.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: We aimed to identify the impact of re-exploration for bleeding after coronary artery bypass grafting (CABG) and the effect of time delay, re-exploration within 12 h (< 12 h) versus 12 h or later (>= 1 2 h). Methods: Analyses of prospective clinical data on 3220 consecutive patients who underwent CABG between 2003 and 2005 were performed. Pearson chi(2) tests, Fisher's exact tests, Student's t-tests, Mann-Whitney U tests, or univariate logistic regression analysis were used to assess the effects of pre-operative and operative characteristics on re-exploration, and the effects of re-exploration and time delay on adverse outcomes. Predictors of re-exploration and its effect on adverse outcomes were further evaluated using multiple logistic regression analysis. Results: One hundred ninety-one patients (5.9%) underwent re-exploration for bleeding. Re-explored patients as a group in comparison to the non-re-explored group had increased postoperative blood loss, transfusion requirements, duration of mechanical ventilation, ICU stay, intra-aortic balloon pump (IABP) and haemofiltration support, and mortality(all p < 0.001). One hundred fifty-seven (82%) of the 191 patients were re-explored < 12 h. The group of patients who were re-explored < 12 h in comparison to >= 12 h group had shorter ICU stay (median 3 vs 8.5 days; p < 0.001), less IABP support (22.3 vs 44.1%; p = 0.009) and a lower mortality (7 vs 29.4%; p = 0.001). There was no significant difference in blood loss or transfusion requirements between the two groups. The predicted EuroSCORE risks of the < 12 h group was 6.66% and the observed mortality was 7% (p = 0.865). The observed mortality of 29.4% in the >= 1 2 h group was significantly higher than the predicted EuroSCORE risks of 7.59% (p < 0.001). Conclusions: Patients requiring re-exploration for bleeding are at higher risk of adverse outcomes and this risk is increased if time to re-exploration is prolonged for 12 h or longer. (c) 2007 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:834 / 838
页数:5
相关论文
共 12 条
[1]   REOPERATION FOR HAEMORRHAGE FOLLOWING CARDIOPULMONARY BY-PASS [J].
CRADDOCK, DR ;
LOGAN, A ;
FADALI, A .
BRITISH JOURNAL OF SURGERY, 1968, 55 (01) :17-&
[2]   Reexploration for hemorrhage following coronary artery bypass grafting - Incidence and risk factors [J].
Dacey, LJ ;
Munoz, JJ ;
Baribeau, YR ;
Johnson, ER ;
Lahey, SJ ;
Leavitt, BJ ;
Quinn, RD ;
Nugent, WC ;
Birkmeyer, JD ;
O'Connor, GT .
ARCHIVES OF SURGERY, 1998, 133 (04) :442-446
[3]   Factors associated with excessive postoperative blood loss and hemostatic transfusion requirements: A multivariate analysis in cardiac surgical patients [J].
Despotis, GJ ;
Filos, KS ;
Zoys, TN ;
Hogue, CW ;
Spitznagel, E ;
Lappas, DG .
ANESTHESIA AND ANALGESIA, 1996, 82 (01) :13-21
[4]   Reexploration for bleeding after coronary artery bypass surgery: Risk factors, outcomes, and the effect of time delay [J].
Karthik, S ;
Grayson, AD ;
McCarron, EE ;
Pullan, DM ;
Desmond, MJ .
ANNALS OF THORACIC SURGERY, 2004, 78 (02) :527-534
[5]   Risk factors for sternal wound infection and mid-term survival following coronary artery bypass surgery [J].
Lu, JCY ;
Grayson, AD ;
Jha, P ;
Srinivasan, AK ;
Fabri, BM .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2003, 23 (06) :943-949
[6]   Hemostatic drugs [J].
Mannucci, PM .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (04) :245-253
[7]   Reexploration for bleeding is a risk factor for adverse outcomes after cardiac operations [J].
Moulton, MJ ;
Creswell, LL ;
Mackey, ME ;
Cox, JL ;
Rosenbloom, M .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1996, 111 (05) :1037-1044
[8]   APROTININ SIGNIFICANTLY DECREASES BLEEDING AND TRANSFUSION REQUIREMENTS IN PATIENTS RECEIVING ASPIRIN AND UNDERGOING CARDIAC OPERATIONS [J].
MURKIN, JM ;
LUX, J ;
SHANNON, NA ;
GUIRAUDON, GM ;
MENKIS, AH ;
MCKENZIE, FN ;
NOVICK, RJ .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1994, 107 (02) :554-561
[9]   Reoperations for bleeding after coronary artery bypass procedures during 25 years [J].
Sellman, M ;
Intonti, MAM ;
Ivert, T .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 1997, 11 (03) :521-527
[10]  
TALAMONTI MS, 1987, AM SURGEON, V53, P102